15
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Can dietary modification reduce the cardiovascular complications of metabolic syndrome? ‘All for one’ or ‘one for all’?

&
Pages 413-416 | Published online: 10 Jan 2014

References

  • Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation120(16), 1640–1645 (2009).
  • Gami AS, Witt BJ, Howard DE et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol.49(4), 403–414 (2007).
  • Thomas GN, Phillips AC, Carroll D, Gale CR, Batty GD. The metabolic syndrome adds utility to the prediction of mortality over its components: the Vietnam experience study. Atherosclerosis210(1), 256–261 (2010).
  • Bayturan O, Tuzcu EM, Lavoie A et al. The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. Arch. Intern. Med.170(5), 478–484 (2010).
  • Truby H, Baic S, de Looy A et al. Randomised controlled trial of four commercial weight loss programmes in the UK: initial findings from the BBC ‘diet trials’. BMJ332(7553), 1309–1314 (2006).
  • Ello-Martin JA, Roe LS, Ledikwe JH, Beach AM, Rolls BJ. Dietary energy density in the treatment of obesity: a year-long trial comparing 2 weight-loss diets. Am. J. Clin. Nutr.85(6), 1465–1477 (2007).
  • Harvie MN, Pegington M, Mattson MP et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int. J. Obes. (Lond.) DOI: 10.1038/ijo.2010.171 (2010) (Epub ahead of print).
  • Keys A. Coronary heart disease in seven countries. Circulation41(Suppl. 4), 163–175 (1970).
  • Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am. J. Clin. Nutr.3, 535–546 (2010).
  • Stamler J. Diet–heart: a problematic revisit. Am. J. Clin. Nutr.91(3), 497–499 (2010).
  • Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids45(10), 893–905 (2010).
  • Vessby B, Uusitupa M, Hermansen K et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia44(3), 312–319 (2001).
  • Jebb SA, Lovegrove JA, Griffin BA et al. Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am. J. Clin. Nutr.92(4), 748–758 (2010).
  • Tierney AC, McMonagle J, Shaw DI et al. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome-LIPGENE: a European randomized dietary intervention study. Int. J. Obes. (Lond.) DOI: 10.1038/ijo.2010.209 (2010) (Epub ahead of print).
  • Moore C, Gitau R, Goff L et al. Successful manipulation of the quality and quantity of fat and carbohydrate consumed by free-living individuals using a food exchange model. J. Nutr.139(8), 1534–1540 (2009).
  • Shaw DI, Tierney AC, McCarthy S et al. LIPGENE food-exchange model for alteration of dietary fat quantity and quality in free-living participants from eight European countries. Br. J. Nutr.101(5), 750–759 (2009).
  • Albert CM, Campos H, Stampfer MJ et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med.346(15), 1113–1118 (2002).
  • Griffin BA. The effect of n-3 fatty acids on low density lipoprotein subfractions. Lipids36, S91–S97 (2001).
  • Wilkinson P, Leach C, Ah-Sing EE et al. Influence of α-linolenic acid and fish-oil on markers of cardiovascular risk in subjects with an atherogenic lipoprotein phenotype. Atherosclerosis181(1), 115–124 (2005).
  • Hussein N, Ah-Sing E, Wilkinson P, Leach C, Griffin BA, Millward DJ. Long-chain conversion of [13C]linoleic acid and α-linolenic acid in response to marked changes in their dietary intake in men. J. Lipid. Res.46(2), 269–280 (2005).
  • Oxlund AL, Heitmann BL. Glycaemic index and glycaemic load in relation to blood lipids – 6 years of follow-up in adult Danish men and women. Public Health Nutr.9(6), 737–745 (2006).
  • Galgani J, Aguirre C, Diaz E. Acute effect of meal glycemic index and glycemic load on blood glucose and insulin responses in humans. Nutr. J.5, 22 (2006).
  • Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab.299(5), E685–E694 (2010).
  • Yki-Jarvinen H. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data. Curr. Opin. Clin. Nutr. Metab. Care13(6), 709–714 (2010).
  • Ferguson JF, Phillips CM, Tierney AC et al. Gene–nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am. J. Clin. Nutr.91(3), 794–801 (2010).
  • Khan S, Minihane AM, Talmud P et al. Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype. J. Lipid. Res.43(6), 979–985 (2002).
  • Keys A. Coronary heart disease in seven countries. Circulation164, 1912–1919 (1970).
  • Rumawas ME, Meigs JB, Dwyer JT, McKeown NM, Jacques PF. Mediterranean-style dietary pattern, reduced risk of metabolic syndrome traits, and incidence in the Framingham Offspring Cohort. Am. J. Clin. Nutr.90(6), 1608–1614 (2009).
  • Jackson KG, Lovegrove JA. The role of monounsaturated fatty acids in the mitigation of insulin resistance. Curr. Cardiovasc. Risk Rep.4, 390–397 (2010).
  • Mirmiran P, Noori N, Zavareh MB, Azizi F. Fruit and vegetable consumption and risk factors for cardiovascular disease. Metabolism58(4), 460–468 (2009).
  • Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr. Metab. Cardiovasc. Dis.18(4), 283–290 (2008).
  • Tighe P, Duthie G, Vaughan N et al. Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: a randomized controlled trial. Am. J. Clin. Nutr.92(4), 733–740 (2010).
  • Brownlee IA, Moore C, Chatfield M et al. Markers of cardiovascular risk are not changed by increased whole-grain intake: the WHOLE heart study, a randomised, controlled dietary intervention. Br. J. Nutr.104(1), 125–134 (2010).
  • Hinderliter AL, Babyak MA, Sherwood A, Blumenthal JA. The DASH diet and insulin sensitivity. Curr. Hypertens. Rep.13(1), 67–73 (2011).
  • McCall DO, McGartland CP, McKinley MC et al. The effect of increased dietary fruit and vegetable consumption on endothelial activation, inflammation and oxidative stress in hypertensive volunteers. Nutr. Metab. Cardiovasc. Dis. DOI: 10.1016/j.numecd.2010.01.009 (2010) (Epub ahead of print).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.